Ayushi Gupta Selected Research

Ayushi Gupta Research Topics

3	COVID-19 05/2023 - 01/2022
2	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 07/2022
2	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2023 - 01/2022
2	Mycoses (Diseases, Fungus) 05/2023 - 07/2022
2	Mucormycosis 05/2023 - 07/2022
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2021
2	Neoplasms (Cancer) 04/2021 - 01/2021
1	Pneumonia (Pneumonitis) 05/2024
1	Nervous System Diseases (Neurological Disorders) 01/2024
1	Demyelinating Diseases (Demyelinating Disease) 08/2023
1	Acquired Immunodeficiency Syndrome (AIDS) 05/2023
1	Diabetes Mellitus 05/2023
1	Coinfection 05/2023
1	Hyperglycemia 07/2022
1	Memory Disorders (Memory Loss) 01/2022
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022
1	Substance-Related Disorders (Drug Abuse) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Cataract (Cataracts) 01/2021
1	Intraoperative Complications 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Hyperuricemia 10/2018

3	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2022
2	SteroidsIBA 05/2023 - 07/2022
1	ProcalcitoninIBA 05/2024
1	C-Reactive ProteinIBA 05/2024
1	CurcuminIBA 04/2024
1	Explosive Agents (Explosives)IBA 05/2023
1	GR24 strigolactoneIBA 07/2022
1	Oxygen (Dioxygen)IBA 07/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	isopelletierineIBA 01/2022
1	Nicotine FDA Link 01/2022
1	PhytochemicalsIBA 01/2022
1	AshwagandhaIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2021
1	Immune Checkpoint ProteinsIBA 01/2021
1	NivolumabIBA 01/2021
1	IpilimumabIBA 01/2021
1	pembrolizumabIBA 01/2021
1	Death Domain ReceptorsIBA 01/2021
1	Xanthine DehydrogenaseIBA 10/2018